Fingerprint
Dive into the research topics where Francesco Cortiula is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pretreatment Risk Model for Radiation-Induced Lymphopenia Is Associated With Adjuvant Durvalumab Efficacy in Patients With Unresectable Stage III NSCLC
van Rossum, P. S. N., Damen, P. J. J., Cortiula, F., Hobbs, B. P., De Marchi, L., Mohan, R., Peters, M., Schneiders, F. L., De Ruysscher, D., Wijsman, R., Verhoeff, J. J. C., Xu, T., Liao, Z. & Lin, S. H., 1 Jan 2026, (E-pub ahead of print) In: International Journal of Radiation Oncology Biology Physics.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future Perspectives
Zanchetta, C., De Marchi, L., Macerelli, M., Pelizzari, G., Costa, J., Aprile, G. & Cortiula, F., Jan 2025, In: International Journal of Molecular Sciences. 26, 1, 221.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer (NSCLC): A prognostic clinical and biomarker-based model
Vaes, R. D. W., Cortiula, F., Lyu, S., Hiltermann, T. J. N., Houben, R., Degens, J., Hendriks, L. E. L. & Ruysscher, D. D., 1 May 2025, In: Lung Cancer. 203, 9 p., 108541.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab
Cortiula, F., Kutiel, T. S., Hsu, M. L., Hendriks, L. E. L., Nassar, A. H., Moskovitz, M., Kim, S. Y., Mirsky, M. M., Jayakrishnan, R., Bortolot, M., Saddi, J., Borghetti, P., Chung, M. J., Filippi, A. R., De Ruysscher, D. & Bar, J., 26 Mar 2025, In: European Journal of Cancer. 219, 8 p., 115302.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
De-Escalation Strategies With Immune Checkpoint Blockers in Non-Small Cell Lung Cancer: Do We Already Have Enough Evidence?
Remon, J., Bortolot, M., Bironzo, P., Cortiula, F., Menis, J., Brandao, M., Naidoo, J., van Geel, R., Reguart, N., Arrieta, O., Mountzios, G., Hendriks, L. E. L. & Besse, B., 20 Mar 2025, In: Journal of Clinical Oncology. 43, 9, p. 1148-1156 11 p., 2402347.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open AccessFile24 Downloads (Pure)